FDA Adverse Event Injury Summary report: N

TENSION FREE VAGINAL TAPE

MDR report key: 3160236 · Received June 10, 2013

Report

Report Number
2210968-2013-06917
Event Type
Injury
Date Received
June 10, 2013
Report Date
May 23, 2013
Manufacturer
ETHICON, INC.
Product Code
PAH
PMA / PMN Number
K052401
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

(B)(4). CONCLUSION: NO CONCLUSION CAN BE DRAWN AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE OBTAINED, A SUPPLEMENTAL 3500A FORM WILL BE SUBMITTED ACCORDINGLY.

Additional Manufacturer Narrative · 1

(B)(4). IT WAS REPORTED THAT THE PATIENT UNDERWENT A GYNECOLOGICAL PROCEDURE AND MESH WAS IMPLANTED CONCURRENTLY WITH CYSTOSCOPY DUE TO STRESS URINARY INCONTINENCE. IT WAS REPORTED THAT PATIENT HAD AN EXCISION BIOPSY OF ABDOMINAL WALL MASS ON (B)(6) 2007. IT WAS REPORTED THAT PATIENT UNDERWENT URETHROLYSIS, SLING REVISION AND CYSTOSCOPY ON (B)(6) 2008 DUE TO VAGINAL WALL MESH EROSION. IT WAS REPORTED THAT PATIENT UNDERWENT A LAPAROSCOPIC CHOLECYSTECTOMY AND CHOLANGIOGRAM ON (B)(6) 2009.

Additional Manufacturer Narrative · 1

IT WAS REPORTED BY AN ATTORNEY THAT THE PATIENT UNDERWENT A GYNECOLOGICAL PROCEDURE ON (B)(6) 2007 AND MESH WAS IMPLANTED. IT WAS REPORTED THAT THE PATIENT UNDERWENT A MINIARC SLING IMPLANTATION ON (B)(6) 2013 DUE TO SUI AND CYSTOCELE GRADE 2. NO ADDITIONAL INFORMATION WAS PROVIDED. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT A SURGICAL PROCEDURE ON (B)(6) 2007 AND MESH WAS IMPLANTED INTO THE PATIENT. IT IS REPORTED THAT THE PATIENT EXPERIENCED PAIN, EROSION OF HER INTERNAL TISSUES, AND SHE HAS UNDERGONE ADDITIONAL SURGERIES AND REVISIONARY PROCEDURES. NO ADDITIONAL INFORMATION IS PROVIDED AT THIS TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
260740 TENSION FREE VAGINAL TAPE MESH, SURGICAL, POLYMERIC PAH ETHICON, INC. NA 2975448

Patients

Seq Age Sex Outcome Treatment
1 57 YR Required Intervention